← Markets

Blackstone Inc.

BX · NYSE

Market open$126.62$-2.35 (-1.82%)

Key statistics

Previous close$128.97
Open$128.37
Day high$131.00
Day low$126.50
52-week high$190.09
52-week low$101.73
Market cap152.10B
Volume2.83M
Average volume5.21M
P/E ratio21.68
Forward P/E—
EPS5.84
Dividend yield+3.93%

Market context

Why it moved

Blackstone shares rose amid growing investor anticipation ahead of the company's upcoming quarterly earnings release scheduled for July 23, with options markets pricing in a notable potential move on the results.

StockinvestIndiatimesZacksFacebookZacks

What is happening

Recent company-specific developments and publisher coverage.

July 17, 2026Blackstone is trading modestly lower, underperforming the broader financial sector as investors digest a wave of analyst price target cuts ahead of the company's Q2 earnings call on July 23. Both JPMorgan and Oppenheimer trimmed their price targets — JPMorgan to $132 (Neutral) and Oppenheimer to $139 (Outperform) — reflecting caution around private credit redemption pressures and a broader AI disruption narrative weighing on the financial services sector. Despite the near-term headwinds, institutional buying remains robust, with Bank of New York Mellon, Calamos, and several other firms adding to positions, and a consensus Moderate Buy rating with an average target near $146.

-1.8415

July 17, 2026Blackstone rose 1.5%, outperforming the broader market as investors positioned ahead of its Q2 earnings call scheduled for July 23. Key catalysts include Blackstone's launch of a new Asia-Pacific infrastructure platform with a high-profile hire from KKR, a $1.15B preferred equity investment in Angelini Pharma's acquisition of Catalyst Pharmaceuticals, and the official launch of 'Ode with Anthropic' — an AI services firm co-founded with Anthropic and Hellman & Friedman. JPMorgan trimmed its price target to $132 (from $136) while maintaining Neutral, though the consensus remains Moderate Buy at ~$146.52, and the financial sector ETF (XLF) traded near 52-week highs amid a strong Wall Street earnings backdrop.

1.4955

July 16, 2026Blackstone shares rose nearly 2%, closing at $127.02, driven by the launch of Ode with Anthropic — a new enterprise AI services firm co-founded with Anthropic and Hellman & Friedman, backed by a high-profile investor consortium including Goldman Sachs, Apollo, and Sequoia Capital. The announcement reinforced Blackstone's expanding AI footprint alongside its previously disclosed $7.8 billion data center sale to Digital Realty, with investors also positioning ahead of its Q2 2026 earnings call scheduled for July 23. Broader tailwinds from strong Wall Street bank earnings and a softer-than-expected PPI report lifted the financial sector, with XLF near its 52-week high; analyst consensus remains a "Moderate Buy" with an average price target of ~$146.52, well above current levels.

1.975

July 15, 2026Blackstone rose over 2% as a robust dealmaking environment and softer-than-expected June CPI data lifted financial stocks broadly. Wall Street banks reported blowout Q2 earnings — JPMorgan posted its highest quarterly profit ever and Goldman Sachs surged 4% — signaling a booming M&A and capital markets backdrop that benefits Blackstone's alternative asset management franchise. Ahead of its own Q2 report, a Seeking Alpha piece flagged BX as attractively valued, and Citizens JMP maintained an Outperform rating with a $165 price target, while the consensus sits at a Moderate Buy with an average target of $147.10.

2.0649

July 14, 2026Blackstone edged lower, weighed by a broader market selloff driven by renewed U.S.-Iran military strikes that sent oil prices surging and rattled risk sentiment. The decline came despite a major deal announcement: Blackstone, alongside Apollo and KKR, committed $5.34 billion to fund Williams Companies' five Power Innovation projects, securing a 49% noncontrolling equity interest in a deal that underscores Blackstone's growing infrastructure and energy push. Analyst sentiment remains mixed, with RBC and Evercore ISI trimming price targets to $161 and $140 respectively while maintaining Outperform ratings, and the stock trades at a notable discount to the consensus target of ~$147.

-0.8368

July 11, 2026Blackstone edged higher Friday as a flurry of deal activity and AI infrastructure momentum kept investor attention focused on the firm's growth pipeline. Blackstone and TPG are reportedly seeking to sell Hologic's surgical unit for over $4 billion, while Barclays is arranging an ~$875 million debt sale tied to Blackstone's acquisition of UK aerospace supplier Senior — both signals of continued private equity and private credit momentum. Adding to the narrative, Blackstone and Apollo structured a complex AI chip financing deal involving Broadcom and Anthropic through a special-purpose vehicle, though questions around risk transfer tempered some enthusiasm. Analyst sentiment remains constructive with a "Moderate Buy" consensus and a $148 average price target, even as Citizens JMP trimmed its target to $165 from $190 while maintaining its "Outperform" view.

0.7614

July 10, 2026Blackstone rose nearly 3%, outpacing the broader financial sector (XLF +0.9%) and S&P 500, driven by a pair of significant deal headlines. The firm is reportedly working with TPG to sell Hologic's surgical business for over $4 billion, signaling active portfolio monetization, while Barclays is arranging ~$875 million in debt financing for Blackstone's acquisition of UK aerospace supplier Senior. Adding to the positive backdrop, Blackstone and Apollo's record $35 billion AI infrastructure financing for Broadcom and Anthropic is set to enter the secondary market, reinforcing the firm's growing role in private credit and AI infrastructure. Analyst sentiment remains mixed — Deutsche Bank nudged its target to $150 while Barclays trimmed its target to $119 — but the consensus leans 'Moderate Buy' at a $140+ mean target, with shares still trading at a meaningful discount to that level.

2.959

July 9, 2026Blackstone declined alongside broader financial sector weakness as geopolitical risk resurfaced sharply — President Trump's declaration that the U.S.-Iran ceasefire was 'over' sent oil prices surging more than 5% and triggered a broad risk-off selloff that weighed on alternative asset managers. The XLF financials ETF closed near its session lows. Adding to the macro headwinds, Jefferies maintained its Buy rating on Blackstone but cut its price target significantly from $207 to $145, reflecting a broader reset in analyst expectations for the alternatives space — though the consensus target of $149.36 still implies meaningful upside. On the positive side, Blackstone announced its first investment from a new energy transition vehicle, acquiring Dresser Utility Solutions from First Reserve, and recent Russell value index additions have bolstered institutional interest.

-1.8943

Data Center Dynamics · July 15, 2026Blackstone invests $5.34bn in Williams' behind-the-meter natural gas power projects for the data center sectorSeeking Alpha · July 15, 2026Blackstone: The Largest Data Center Investor Is On Sale Yielding 3.8% (NYSE:BX)PE Hub · July 15, 2026Blackstone, Hellman & Friedman and Anthropic launch AI services provider, as PE firms team up with AI specialistsReuters · July 9, 2026Blackstone, TPG seek over $4 billion for Hologic's surgical unit, FT saysMoomoo · July 7, 2026Jefferies Maintains Blackstone(BX.US) With Buy Rating, Cuts Target Price to $145Reuters · May 28, 2026Apollo, Blackstone work on $36 billion debt deal for Anthropic, Bloomberg News reportsStock Titan · May 13, 2026New Blackstone data center trust IPO could raise up to $2B in NYSE offeringStockStory · March 30, 2026Why Blackstone (BX) Stock Is Up Today
Benzinga · July 17, 2026Oppenheimer Maintains Outperform on Blackstone, Lowers Price Target to $139
Mt Newswire · July 17, 2026Oppenheimer Adjusts Price Target on Blackstone to $139 From $156, Maintains Outperform Rating
Benzinga · July 16, 2026$100 Invested In Blackstone 15 Years Ago Would Be Worth This Much Today
Benzinga · July 16, 2026JP Morgan Maintains Neutral on Blackstone, Lowers Price Target to $132
Mt Newswire · July 16, 2026Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals
Mt Newswire · July 16, 2026JPMorgan Adjusts Price Target on Blackstone to $132 From $136, Maintains Neutral Rating
Mt Newswire · July 15, 2026Sector Update: Financial Stocks Rise Wednesday Trading
Mt Newswire · July 15, 2026Blackstone, Anthropic, Hellman & Friedman Unveil Enterprise AI Services Firm

Peers

S&P 500SPX · $7,462.39-0.95%BlackRock, Inc.BLK · $1,072.02-1.38%KKR & Co. Inc.KKR · $100.43-2.26%Apollo Global Management, Inc.APO · $119.62-3.02%The Carlyle Group Inc.CG · $45.89-1.59%Ares Management CorporationARES · $124.59-0.67%TPG Inc.TPG · $43.50-1.51%Brookfield Asset Management Ltd.BAM · $48.22-2.73%Brookfield CorporationBN · $43.43-1.98%EQT AB (publ)EQT.ST · 318.30+11.02%Hamilton Lane IncorporatedHLNE · $85.46-0.51%Blue Owl Capital Inc.OWL · $9.53-0.99%